Three-year clinical experience with the long-acting injectable formulation of the atypical antipsychotic risperidone

被引：0

作者：

Christina Leotsakou

Sofia Kessidou

Aikaterini Kalogeropoulou

Ioanna Fotara

Perikles Robotis

Christina Karkatzouli

Demetrios Gousis

Athanasios Demetriades

Maria Giovanoglou

Perikles Paterakis

机构：

[1] Dromokaition Psychiatric Hospital,

[2] Social Insurance Institute Glyfada,undefined

来源：

Annals of General Psychiatry | / 7卷 / Suppl 1期

关键词：

Schizophrenia; Risperidone; Antipsychotic Drug; Atypical Antipsychotic; Adverse Event Profile;

D O I：

10.1186/1744-859X-7-S1-S131

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[1] Clinical experience with the long-acting injectable formulation of the atypical antipsychotic, risperidone
Martin, SD
Libretto, SE
Pratt, DJ
Brewin, JS
Huq, ZU
Saleh, BT
[J]. CURRENT MEDICAL RESEARCH AND OPINION, 2003, 19 (04) : 298 - 305
[2] Long-acting injectable risperidone: Efficacy and safety of the first long-acting atypical antipsychotic
Kane, JM
Eerdekens, M
Lindenmayer, JP
Keith, SJ
Lesem, M
Karcher, K
[J]. AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (06): : 1125 - 1132
[3] Long-acting, injectable risperidone - the first long-acting, atypical antipsychotic - improves quality of life
Nasrallah, H
Duchesne, I
Mehnert, A
Janagap, C
[J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S282 - S282
[4] Clinical review of a long-acting, injectable formulation of risperidone
Knox, ED
Stimmel, GL
[J]. CLINICAL THERAPEUTICS, 2004, 26 (12) : 1994 - 2002
[5] Clinical profile of long-acting risperidone - the first atypical depot antipsychotic
Pajonk, FG
Messer, T
Heger, S
Schmauss, M
[J]. PSYCHOPHARMAKOTHERAPIE, 2002, 9 (04): : 140 - +
[6] Long-acting injectable risperidone
Ehret, MJ
Fuller, MA
[J]. ANNALS OF PHARMACOTHERAPY, 2004, 38 (12) : 2122 - 2127
[7] Long-acting injectable atypical antipsychotic: a relapse risk study
Dejean, C.
Chabaud, F.
Pigeot, E.
Bouet, R.
Richard, D.
Levy-Chavagnat, D.
[J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2011, 25 : 96 - 97
[8] An atypical long-acting injectable antipsychotic: implications for pharmacotherapy of schizophrenia
Dursun, S
[J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2005, 19 (05) : 3 - 4
[9] A review of compliance, depot intramuscular antipsychotics and the new long-acting injectable atypical antipsychotic risperidone in schizophrenia
Bhanji, NH
Chouinard, G
Margolese, HC
[J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 (02) : 87 - 92
[10] Improved symptom control with risperidone long-acting injectable in psychotic patients previously treated with an oral atypical antipsychotic
Glue, P
Chrzanowski, W
Kissling, W
Buccomino, D
Medori, R
Parellada, E
[J]. EUROPEAN PSYCHIATRY, 2005, 20 : S79 - S79

← 1 2 3 4 5 →